Cell Sensitivity Assays: The MTT Assay
- 24 March 2011
- book chapter
- Published by Springer Science and Business Media LLC
- Vol. 731, 237-245
- https://doi.org/10.1007/978-1-61779-080-5_20
Abstract
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay is based on the conversion of MTT into formazan crystals by living cells, which determines mitochondrial activity. Since for most cell populations the total mitochondrial activity is related to the number of viable cells, this assay is broadly used to measure the in vitro cytotoxic effects of drugs on cell lines or primary patient cells. In this chapter the protocol of the assay is described including important considerations relevant for each step of the assay as well as its limitations and possible applications.Keywords
This publication has 7 references indexed in Scilit:
- Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 proteinBlood, 2008
- Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemiaEuropean Journal of Cancer, 2005
- TrueLeukemia, 1999
- In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic LeukemiaBlood, 1997
- Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assayBritish Journal of Cancer, 1994